No Data
Express News | Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
H.C. Wainwright Initiates Avidity Biosciences(RNA.US) With Buy Rating, Announces Target Price $72
This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Avidity Biosciences Price Target Announced at $72.00/Share by HC Wainwright & Co.
Avidity Biosciences Initiated at Buy by HC Wainwright & Co.